在质瘤中PIM-1激酶的表达和预后值
Zelin Li1, Hu Wang2, Guangxiu Wang3
1Clinical College of Neurology, Neurosurgery and Neurorehabilitation, Tianjin Medical University, Tianjin, PR China.
Histology and histopathology
|November 21, 2024
概括
原瘤基因血清蛋白/氨酸蛋白激酶1 (PIM-1) 在质瘤中过度表达,与瘤等级相关. PIM-1可以作为预后生物标志物和治疗质瘤患者的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 质瘤是一种主要的大脑瘤,具有复杂的分子格局.
- 了解像PIM-1这样的特定基因的作用对于改善患者的治疗结果至关重要.
- 原型瘤基因血清蛋白/氨酸蛋白激酶1 (PIM-1) 与各种癌症有关.
研究的目的:
- 研究质瘤患者的PIM-1表达和临床病理特征之间的相关性.
- 评估PIM-1在质瘤中的预后价值.
- 探索PIM-1和瘤免疫微环境之间的关系.
主要方法:
- 西方斑块和免疫组织化学被用来检测MTERF3表达.
- 公共数据库 (GIPIA,GETx,TCGA) 用于分析PIM-1表达和质瘤中的存活率.
- 瘤免疫估计资源 (TIMER) 和瘤和免疫系统相互作用数据库 (TISIDB) 用于研究PIM-1与免疫细胞和化学因子的关联.
- 卡普兰-梅尔图表被生成以评估PIM-1表达和患者存活率之间的相关性.
主要成果:
- 在质瘤中,PIM-1表达被上调,与瘤等级正相关.
- 传染后PIM-1表达显著受抑制,最大的抑制在第六天观察到.
- 同表达分析揭示了数千个与PIM-1正负相关的基因.
- 在低度质瘤中,PIM-1表达与巨细胞,髓状树突细胞,NK细胞,CD4 T细胞,癌症相关纤维细胞和中性粒细胞呈正相关性.
结论:
- 在质瘤中,PIM-1过度表达,与多型质母细胞瘤的预后有关.
- PIM-1显示出作为质瘤预后生物标志物的潜力.
- PIM-1可能是治疗质瘤治疗的可行治疗标.
更多相关视频
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
7.8K
09:24Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing
Published on: June 9, 2016
9.0K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
